SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-14-000058
Filing Date
2014-07-31
Accepted
2014-07-31 17:08:30
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2014q210-q.htm 10-Q 1426866
2 EXHIBIT 10.2 creditagreement.htm EX-10.2 932703
3 EXHIBIT 31.1 a2014q210-q_exhibit311.htm EX-31.1 14505
4 EXHIBIT 31.2 a2014q210-q_exhibit312.htm EX-31.2 14339
5 EXHIBIT 32.1 a2014q210-q_exhibit321.htm EX-32.1 11731
  Complete submission text file 0000875320-14-000058.txt   9516995

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vrtx-20140630.xml EX-101.INS 1450791
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20140630.xsd EX-101.SCH 53704
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20140630_cal.xml EX-101.CAL 83772
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20140630_def.xml EX-101.DEF 189724
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20140630_lab.xml EX-101.LAB 653778
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20140630_pre.xml EX-101.PRE 336751
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 141007089
SIC: 2834 Pharmaceutical Preparations